A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea

被引:3
作者
Seo, Ji-Hye [1 ]
Kim, Ock-Joo [1 ]
Yoo, Sang-Ho [2 ]
Choi, Eun Kyung [3 ]
Park, Ji-Eun [4 ]
机构
[1] Seoul Natl Univ, Dept Hist Med & Med Humanities, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
[2] Hanyang Univ, Dept Med Human & Eth, Coll Med, Seoul, South Korea
[3] Korea Natl Inst Bioeth Policy, Seoul, South Korea
[4] Korea Inst Oriental Med, KM Data Div, Daejeon, South Korea
关键词
phase I clinical trials; healthy volunteers; informed consent; research ethics;
D O I
10.1177/15562646211034275
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The phase I trial is the first step in administering a drug to humans, but it has no therapeutic purpose. Under the absence of therapeutic purpose, healthy volunteers demonstrated different motivations, unlike the actual patients participating in trials. There were many reported motivations, such as financial motivation, contributing to the health science, accessing ancillary health care benefits, scientific interest or interest in the goals of the study, meeting people, and general curiosity. The aim of this study was to identify the motivation and characteristics of healthy volunteers participating in phase I trials in the Republic of Korea. We gave surveys to 121 healthy volunteers to study their demographic characteristics and the reasons of participation. We identified whether the decision to participate in the research was influenced by demographic factors and whether the perception and attitudes toward the research were influenced by the characteristics of the healthy volunteers. After completion of the first survey, 12 healthy volunteers who had participated in a phase I clinical trial were selected to answer the second interview. According to our survey, most healthy volunteers were unmarried men and economically dependent. Most of them participated in the study because of financial reward. The most important factor to measure financial reward was the research period. Also, 43% of the volunteers were university students, 42% answered "university graduation" and 55% were residing in family-owned houses. Many healthy volunteers were found to be living in family homes and to have a student status or lack of economic independence. Results of the survey showed that 64% of respondents indicated having more than one clinical trial participation. In-depth interviews showed that healthy volunteers had diverse motivation to participate in research and that healthy volunteer perceive the clinical trial positively. The main motivation for healthy volunteers' participation in research was "financial reward." Healthy volunteers also considered research schedules, processes, and safety, and had a positive perception of clinical trials, but they thought that the public has a negative perception.
引用
收藏
页码:193 / 212
页数:20
相关论文
共 50 条
  • [41] Patients’ reasoning regarding the decision to participate in clinical cancer trials: an interview study
    Pia Dellson
    Kerstin Nilsson
    Helena Jernström
    Christina Carlsson
    [J]. Trials, 19
  • [42] Phase I clinical trials in oncology: Ethical issues
    Goldwasser, F
    [J]. THERAPIE, 2004, 59 (04): : 431 - 433
  • [43] Paradoxes of care in phase I cancer clinical trials
    Derbez, Benjamin
    [J]. SCIENCES SOCIALES ET SANTE, 2018, 36 (01): : 5 - 29
  • [44] The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory study
    Catania, C.
    Radice, D.
    Spitaleri, G.
    Adamoli, L.
    Noberasco, C.
    Delmonte, A.
    Vecchio, F.
    de Braud, F.
    Toffalorio, F.
    Goldhirsch, A.
    De Pas, T.
    [J]. PSYCHO-ONCOLOGY, 2014, 23 (03) : 322 - 329
  • [45] Factors Influencing Participation Of Healthy Volunteers In Clinical Trials: Findings From A Cross-Sectional Study In Delhi, North India
    Ranjan, Rajesh
    Agarwal, Nidhi Bharal
    Kapur, Prem
    Marwah, Amit
    Parveen, Rizwana
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 2007 - 2015
  • [46] 'Becoming-with' a repeat healthy volunteer: Managing and negotiating trust among repeat healthy volunteers in commercial clinical drug trials
    Mwale, Shadreck
    [J]. SOCIAL SCIENCE & MEDICINE, 2020, 245
  • [47] The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers
    Moschetti, Viktoria
    Kim, Maria
    Sand, Michael
    Wunderlich, Glen
    Andersen, Grit
    Feifel, Ulrich
    Jang, In-Jin
    Timmer, Wolfgang
    Rosenbrock, Holger
    Boland, Katja
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (05) : 643 - 655
  • [48] Healthy volunteers for bioequivalence trials: predictive factors for enrollment failures - a case-control study
    Yerino, G. A.
    Halabe, E. K.
    Feleder, E. C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (03) : 231 - 236
  • [49] ADVERSE EVENTS IN PHASE ONE STUDIES - A STUDY IN 430 HEALTHY-VOLUNTEERS
    SIBILLE, M
    DEIGAT, N
    OLAGNIER, V
    DURAND, DV
    LEVRAT, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (04) : 389 - 393
  • [50] CRITICAL LIMIT OF BILIRUBIN CONCENTRATION FOR SELECTION OF HEALTHY-VOLUNTEERS TO PHASE-I STUDIES
    OLAGNIER, V
    SIBILLE, M
    DURAND, DV
    DEIGAT, N
    BALTASSAT, P
    LEVRAT, R
    [J]. THERAPIE, 1993, 48 (06): : 617 - 622